Shah Pritesh

Average Profitability
85.52%
Insider Buys Quantity
1
Insider Buys Sum
$357,054.18
Insider Sells Quantity
50
Insider Sells Sum
$31.53M

Insider Activity of Shah Pritesh

According to the SEC Form 4 filings, Shah Pritesh, being in a position of

  1. Chief Growth Officer at NovoCure Limited,
    оver the last 12 months, has bought 0 shares, and sold 382 shares for $4,832,
    over all time since 2018-12-12, has bought 4200 shares for $357,054, and sold 475624 shares for $31.53M.

The largest purchase of all time was on 2020-09-02 and amounted to 4200 shares of NovoCure Limited for $357,054.

The largest sale of all time was on 2021-06-10 and amounted to 23540 shares of NovoCure Limited for $5.06M.

Biography of Shah Pritesh

No biography is available at this moment.

2023-11-07SaleNovoCure Limited
NVCR
Chief Growth Officer
382
0.0004%
$12.65$4,832+19.57%
2023-09-01SaleNovoCure Limited
NVCR
Chief Growth Officer
273
0.0003%
$21.82$5,956-33.09%
2023-03-03SaleNovoCure Limited
NVCR
Chief Growth Officer
21,421
0.0198%
$76.16$1.63M-73.53%
2023-03-02SaleNovoCure Limited
NVCR
Chief Growth Officer
937
0.0009%
$75.28$70,535-71.96%
2023-03-01SaleNovoCure Limited
NVCR
Chief Growth Officer
1,923
0.0018%
$76.36$146,845-71.92%
2023-01-05SaleNovoCure Limited
NVCR
Chief Commercial Officer
387
0.0003%
$108.00$41,796-65.87%
2022-09-02SaleNovoCure Limited
NVCR
Chief Commercial Officer
269
0.0003%
$79.04$21,261-9.1%
2022-03-09SaleNovoCure Limited
NVCR
Chief Commercial Officer
3,669
0.0035%
$71.19$261,196+8.35%
2022-03-07SaleNovoCure Limited
NVCR
Chief Commercial Officer
2,481
0.0024%
$70.10$173,918+11.6%
2022-03-03SaleNovoCure Limited
NVCR
Chief Commercial Officer
1,914
0.0017%
$70.41$134,759+4.71%
2021-09-03SaleNovoCure Limited
NVCR
Chief Commercial Officer
501
0.0005%
$138.68$69,477-42.22%
2021-09-02SaleNovoCure Limited
NVCR
Chief Commercial Officer
156
0.0001%
$138.23$21,564-42.95%
2021-08-04SaleNovoCure Limited
NVCR
Chief Commercial Officer
2,063
0.0019%
$148.71$306,789-46.78%
2021-08-03SaleNovoCure Limited
NVCR
Chief Commercial Officer
1,654
0.0016%
$149.43$247,157-45.2%
2021-06-10SaleNovoCure Limited
NVCR
Chief Commercial Officer
23,540
0.0225%
$215.00$5.06M-59.69%
2021-05-05SaleNovoCure Limited
NVCR
Chief Commercial Officer
1,290
0.0012%
$199.67$257,574-45.73%
2021-05-04SaleNovoCure Limited
NVCR
Chief Commercial Officer
1,043
0.001%
$200.86$209,493-44.16%
2021-03-09SaleNovoCure Limited
NVCR
Chief Commercial Officer
3,524
0.0034%
$131.09$461,961-1.4%
2021-03-08SaleNovoCure Limited
NVCR
Chief Commercial Officer
2,627
0.0026%
$130.81$343,627+1.98%
2021-03-05SaleNovoCure Limited
NVCR
Chief Commercial Officer
4,550
0.0045%
$131.53$598,462+0.53%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.